MORINGA OLEIFERA AS A NUTRITIONAL SUPPLEMENT ON HIV PATIENTS ON ANTIRETROVIRAL THERAPY IN NIGERIA

EVALUATION OF THE ADDITION OF MORINGA OLEIFERA AS A NUTRITIONAL SUPPLEMENT ON THE ANTHROPOMETRIC, VIRAL LOAD AND CD4 COUNTS OF HIV PATIENTS ON ANTIRETROVIRAL THERAPY IN NIGERIA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201811722056449

Enrollment

172

Registered

2018-11-13

Start date

2017-09-04

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Interventions

Moringa Oleifera Leaves powder

Coloured Corn starch powder

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Being HIV sero-positive 2. Patients = 18 years old 3. Patients with CD4 counts = 500 cells/mm3 4. Commenced ART at least for three months (Tenofovir + Lamivudine + Efavirenz combination). 5. Be willing to give informed consent and comply with study protocol

Exclusion criteria

Exclusion criteria: 1. Known allergy or intolerance to Moringa oleifera or placebo (cornstarch powder) 2. Pregnant women 3. Patients with CD4 counts > 500 cells/mm3 4. Patients with active opportunistic infection 5. Patients taking anti-coagulant, micronutrient or natural health product supplements within 30days of randomization 6. Patients with poor or suboptimal adherence to ART medication 7. For ease of monitoring and to achieve maximum compliance to study protocol, patients living outside Kano metropolis will be excluded.

Design outcomes

Primary

Measure	Time frame
Change in immunological status: a.CD4;Change in immunological status: b. Viral load ;Change in anthropometric parameters ( weight, BMI, waist-hip circumference & mid-arm circumference); Occurrence and frequency of opportunistic infections	—

Secondary

Measure	Time frame
Patients’ quality of life (QoL)	—

Countries

Nigeria

Contacts

Public ContactIndres Moodley

Supervisor

Moodleyi15@ac.za+27837041948

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026